advertising
-
1
Dunn JE, Link CL, Felson DT, et al: Prevalence of foot and ankle conditions in a multiethnic community sample of older adults. Am J Epidemiol 159: 491, 2004.
-
2
Dockery GL, Crawford ME: “Mechanical Injuries,” in Cutaneous Disorders of the Lower Extremity, p 235, WB Saunders, Philadelphia, 1997.
-
3
Spink MJ, Menz HB, Lord SR: Distribution and correlates of plantar hyperkeratotic lesions in older people. J Foot Ankle Res 2: 8, 2009.
-
4
Engler GL, Gibbs RC: Common plantar hyperkeratoses. J Dermatol Surg 1: 59, 1975.
-
5
Freeman DB: Corns and calluses resulting from mechanical hyperkeratosis. Am Fam Physician 65: 2277, 2002.
-
6
Thomas SE, Dykes PJ, Marks R: Plantar hyperkeratosis: a study of callosities and normal plantar skin. J Invest Dermatol 85: 394, 1985.
-
7
Kwan RLC, Zheng YP, Cheing GLY: The effect of aging on the biomechanical properties of plantar soft tissues. Clin Biomech 25: 601, 2010.
-
8
Waldecker U, Lehr HA: Is there histomorphological evidence of plantar metatarsal fat pas atrophy in patients with diabetes? J Foot Ankle Surg 48: 648, 2009.
-
9
Waldecker U: Plantar fat pad atrophy: a cause of metatarsalgia? J Foot Ankle Surg 40: 21, 2001.
-
10
Lucke T, Munro C, Roberts D, et al: “Dermatological Conditions of the Foot and Leg” in Neale's Disorders of the Foot, 7th Ed, edited by D Lorimer, G French, M O'Donnell, et al, p 23, Churchill Livingstone Elsevier, Philadelphia, 2006.
-
11
Balkin SW: “Injectable Silicone and the Foot,” in Neale's Disorders of the Foot, 6th Ed, edited by D Lorimer, G French, M O'Donnell, et al, p 471, Churchill Livingstone, Edinburgh, 2002.
-
12
Balkin SW: Injectable silicone and the foot: a 41-year clinical and histologic history. Dermatol Surg 31: 1555, 2005.
-
13
van Chie CHM, Whalley A, Vileikyte L, et al: Efficacy of injected liquid silicone in the diabetic foot to reduce risk factors for ulceration. Diabetes Care 23: 634, 2000.
-
14
Wallace WD, Balkin SW, Kaplan L, et al: The histologic host response to liquid silicone injections for prevention of pressure-related ulcers of the foot: a 38-year study. JAPMA 94: 550, 2004.
-
15
Orentreich DS, Orentreich N: “Injectable Fluid Silicone,” in Roenigk's Dermatologic Surgery, 3rd Ed, edited by RK Roenigk, JL Ratz, HH Roenigk, p 719, Informa Healthcare, New York, 2007.
-
16
Hotta T: Dermal fillers: the next generation. Plast Surg Nurs 24: 14, 2004.
-
17
Tezel A, Fredrickson GH: The science of hyaluronic acid dermal fillers. J Cosmet Laser Ther 10: 35, 2008.
-
18
Vedamurthy M: Soft tissue augmentation: use of hyaluronic acid as dermal filler. Indian J Dermatol Venereol Leprol 70: 383, 2004.
-
19
Price RD, Berry MG, Navsaria HA: Hyaluronic acid: the scientific and clinical evidence. J Plast Reconstr Aesthet Surg 60: 1110, 2007.
-
20
Bygrave CJ, Betts RP: The plantar tissue thickness in the foot: a new ultrasound technique for loadbearing measurements and a metatarsal head depth study. The Foot 2: 71, 1992.
-
21
Muller S, Roddy E: A Rasch analysis of the Manchester Foot Pain and Disability Index. J Foot Ankle Res 2: 29, 2009.
-
22
Landorf KB, Radford JA: Minimal important difference: values for the Foot Health Status Questionnaire, Foot Function Index and Visual Analogue Scale. The Foot 18: 15, 2008.
-
23
Shumaker PR, Rao J, Goldman MP: Treatment of local, persistent cutaneous atrophy following corticosteroid injection with normal saline infiltration. Dermatol Surg 31: 1340, 2005.
Use of Hyaluronic Acid Gel Filler versus Sterile Water in the Treatment of Intractable Plantar Keratomas
A Pilot Study
Search for other papers by Magali Brousseau-Foley in
Current site
Google Scholar
PubMed
Search for other papers by Vincent Cantin in
Current site
Google Scholar
PubMed
Background
Intractable plantar keratoma is a common concern in the podiatric medical office. Different treatment options are available, ranging from trimming and padding to surgery. We sought to investigate the use of hyaluronic acid gel injections as a possible minimally invasive alternative in the treatment of intractable plantar keratomas.
Methods
Seventeen patients with intractable plantar keratomas were randomly assigned to receive a hyaluronic acid gel injection or a sterile water injection at the site of a previously trimmed plantar lesion.
Results
There was no significant difference between the two groups in the evaluation of pain and function at 12 weeks, but both groups showed a clinically relevant improvement. No significant change was observed in plantar tissue thickness in both groups. A minor adverse reaction was seen in the hyaluronic acid group.
Conclusions
The use of a hyaluronic acid gel injection at the site of a trimmed intractable plantar keratoma did not seem more effective than the use of a sterile water injection. Sterile water injections seemed safe and efficient in reducing pain associated with plantar keratomas. Further investigations should concentrate on whether these results are reproducible in a larger sample and on the most effective sequence of treatment.
advertising
